Compare
Cigna vs Veracyte (CI vs VCYT)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Cigna (CI) returned +13.1% and Veracyte (VCYT) -47.5%; so far this year the figures are +6.7% and -42.6%.
Cigna is the larger company by market value, about 39.7 times the size of Veracyte.
On trailing earnings, CI trades at 12.9 times and VCYT at 15.7 times.
Revenue grew +6.8% at CI and +17.5% at VCYT over the last year.
CI yields 2.11%. VCYT pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| CI | VCYT | |
|---|---|---|
| Price | $293.59 | $24.16 |
| 1-day | -2.62% | +0.67% |
| YTD | +6.67% | -42.61% |
| 1 year | +13.10% | -47.52% |
| 3 years | -5.11% | +14.72% |
| Market cap | $77.4B | $1.9B |
| P/E | 12.9 | 15.7 |
| P/S | 0.27 | 3.35 |
| P/B | 1.78 | 1.36 |
| Revenue growth | +6.80% | +17.50% |
| EPS growth | +0.30% | +305.30% |
| Gross margin % | 20.7 | 72.0 |
| Net margin % | 2.1 | 21.8 |
| ROE % | 13.8 | 8.9 |
| Debt / equity | 0.72 | 0.00 |
| FCF yield % | 12.2 | 8.3 |
| Dividend yield % | 2.11 | — |
| Beta | 0.08 | 3.26 |
| RSI (14) | 49.6 | 24.8 |
| Technical rating |